# Cizzle Biotechnology to take early lung cancer test to £3b China market (Interview)

- Link: https://www.directorstalkinterviews.com/cizzle-biotechnology-to-take-early-lung-cancer-test-to-3b-china-market-interview/4121050197
- Published: 2022-02-04T07:31:05+00:00
- Author: Giles

**Cizzle Biotechnology Holdings plc** (LON:CIZ) Executive Chairman Allan Syms joins
DirectorsTalk Interviews to discuss a full commercial development and royalty agreement
to develop and market Cizzle Biotechnologies early lung cancer diagnostic tests 
in China.

Allan provides us with more information around the deal, tells us about the diagnostic
technology and what it does, explains who its partners are in China and how this
arrangement in China will work from a financial point of view and potentially generate
future revenues for the company.

Cizzle Biotechnology is a UK based developer of a blood test for the early detection
of a majority of different forms of lung cancer.

Share on:
